4-WEEK OPEN-LABEL CONTROLLED RANDOMIZED COMPARATIVE STUDY OF THE INJECTABLE AND TABLETTED FORMULATIONS OF METHOTREXATE IN RHEUMATOID ARTHRITIS

4-WEEK OPEN-LABEL CONTROLLED RANDOMIZED COMPARATIVE STUDY OF THE INJECTABLE AND TABLETTED FORMULATIONS OF METHOTREXATE IN RHEUMATOID ARTHRITIS

Objective: to estimate the advantages and disadvantages of using the injectable formulation of methotrexate (MT) (Methoject (MTJ)) in rheumatoid arthritis (RA) in clinical practice. Subjects and methods. A 24-week open-label controlled randomized comparative study evaluated the therapeutic and side...

ver descrição completa

Detalhes bibliográficos
Principais autores: Yu. V. Muravyev, L. N. Denisov, A. V. Alekseyeva, N. V. Muravyeva, E. L. Shakhramanova, K. A. Kasumova, D. A. Gukasyan, I. S. Dydykina, V. V. Lebedeva, E. L. Nasonov
Formato: Artigo
Idioma:Russian
Publicado em: IMA PRESS LLC 2011-06-01
coleção:Научно-практическая ревматология
Assuntos:
rheumatoid arthritis
methotrexate
methoject
injectable formulation
tabletted formulation
adverse reactions
Acesso em linha:https://rsp.mediar-press.net/rsp/article/view/1294

Internet

https://rsp.mediar-press.net/rsp/article/view/1294

Registros relacionados